Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa
Contributors
Taylor, Walter Robert John; Naw, Htee Khu; Maitland, KathrynPublished in
BMC medicine, vol. 16, no. 1, 11Publication date
2018-01-18First online date
2018-01-18Abstract
Keywords
- Age-based dosing
- Malaria
- Plasmodium falciparum
- Primaquine
- Transmission blocking
- Adolescent
- Adult
- Africa South of the Sahara
- Age Factors
- Aged
- Aged, 80 and over
- Antimalarials / administration & dosage
- Antimalarials / adverse effects
- Antimalarials / therapeutic use
- Child
- Child, Preschool
- Clinical Protocols
- Dose-Response Relationship, Drug
- Female
- Glucosephosphate Dehydrogenase Deficiency
- Humans
- Infant
- Malaria, Falciparum / drug therapy
- Malaria, Falciparum / prevention & control
- Malaria, Falciparum / transmission
- Male
- Middle Aged
- Plasmodium falciparum
- Primaquine / administration & dosage
- Primaquine / adverse effects
- Primaquine / therapeutic use
- Young Adult
UNIGE affiliation entities
Funding
- Wellcome Trust - Core Support for the East African Major Overseas Programme [203077]
- Wellcome Trust - The health consequences of genetic variants that have been selected by malaria, with a particular focus on polymorphisms affecting the red blood cell [202800]
Citation (ISO format)
TAYLOR, Walter Robert John et al. Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan Africa. In: BMC medicine, 2018, vol. 16, n° 1, p. 11. doi: 10.1186/s12916-017-0990-6
Main files (1)
Article (Published version)
Secondary files (2)
Appendix
Appendix
Identifiers
- PID : unige:158209
- DOI : 10.1186/s12916-017-0990-6
- PMID : 29347975
- PMCID : PMC5774032
